57 related articles for article (PubMed ID: 28882999)
1. miR-193b-Regulated Signaling Networks Serve as Tumor Suppressors in Liposarcoma and Promote Adipogenesis in Adipose-Derived Stem Cells.
Mazzu YZ; Hu Y; Soni RK; Mojica KM; Qin LX; Agius P; Waxman ZM; Mihailovic A; Socci ND; Hendrickson RC; Tuschl T; Singer S
Cancer Res; 2017 Nov; 77(21):5728-5740. PubMed ID: 28882999
[TBL] [Abstract][Full Text] [Related]
2. Immune profiling of dedifferentiated liposarcoma and identification of novel antigens for targeted immunotherapy.
Jirovec A; Flaman A; Godbout E; Serrano D; Werier J; Purgina B; Diallo JS
Sci Rep; 2024 May; 14(1):11254. PubMed ID: 38755218
[TBL] [Abstract][Full Text] [Related]
3. miR-181a modulates circadian rhythm in immortalized bone marrow and adipose derived stromal cells and promotes differentiation through the regulation of PER3.
Knarr M; Nagaraj AB; Kwiatkowski LJ; DiFeo A
Sci Rep; 2019 Jan; 9(1):307. PubMed ID: 30670712
[TBL] [Abstract][Full Text] [Related]
4. Liposarcoma: molecular targets and therapeutic implications.
Bill KL; Casadei L; Prudner BC; Iwenofu H; Strohecker AM; Pollock RE
Cell Mol Life Sci; 2016 Oct; 73(19):3711-8. PubMed ID: 27173057
[TBL] [Abstract][Full Text] [Related]
5. FAK-targeting PROTAC as a chemical tool for the investigation of non-enzymatic FAK function in mice.
Gao H; Zheng C; Du J; Wu Y; Sun Y; Han C; Kee K; Rao Y
Protein Cell; 2020 Jul; 11(7):534-539. PubMed ID: 32451721
[No Abstract] [Full Text] [Related]
6. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.
;
Cell; 2017 Nov; 171(4):950-965.e28. PubMed ID: 29100075
[TBL] [Abstract][Full Text] [Related]
7. Rb and p53-Deficient Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma Require Skp2 for Survival.
Li GZ; Okada T; Kim YM; Agaram NP; Sanchez-Vega F; Shen Y; Tsubokawa N; Rios J; Martin AS; Dickson MA; Qin LX; Socci ND; Singer S
Cancer Res; 2020 Jun; 80(12):2461-2471. PubMed ID: 32161142
[TBL] [Abstract][Full Text] [Related]
8. Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.
Thway K
Semin Diagn Pathol; 2019 Mar; 36(2):112-121. PubMed ID: 30852045
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Molecular Spectrum of Liposarcoma.
Lee ATJ; Thway K; Huang PH; Jones RL
J Clin Oncol; 2018 Jan; 36(2):151-159. PubMed ID: 29220294
[TBL] [Abstract][Full Text] [Related]
10. The Immune Contexture of Liposarcoma and Its Clinical Implications.
Resag A; Toffanin G; Benešová I; Müller L; Potkrajcic V; Ozaniak A; Lischke R; Bartunkova J; Rosato A; Jöhrens K; Eckert F; Strizova Z; Schmitz M
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230502
[TBL] [Abstract][Full Text] [Related]
11. Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence.
Zhang S; Yan L; Cui C; Wang Z; Wu J; Zhao M; Dong B; Guan X; Tian X; Hao C
Oncol Rep; 2020 Aug; 44(2):565-576. PubMed ID: 32627015
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive immune characterization and T-cell receptor repertoire heterogeneity of retroperitoneal liposarcoma.
Yan L; Wang Z; Cui C; Guan X; Dong B; Zhao M; Wu J; Tian X; Hao C
Cancer Sci; 2019 Oct; 110(10):3038-3048. PubMed ID: 31385405
[TBL] [Abstract][Full Text] [Related]
13. Identification of NINJ1 as a novel prognostic predictor for retroperitoneal liposarcoma.
Zhao Y; Qin D; Li X; Wang T; Zhang T; Rao X; Min L; Wan Z; Luo C; Xiao M
Discov Oncol; 2024 May; 15(1):155. PubMed ID: 38733554
[TBL] [Abstract][Full Text] [Related]
14. Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection.
Lesovaya EA; Fetisov TI; Bokhyan BY; Maksimova VP; Kulikov EP; Belitsky GA; Kirsanov KI; Yakubovskaya MG
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254762
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human Meningiomas.
Kober P; Mossakowska BJ; Rusetska N; Baluszek S; Grecka E; Konopiński R; Matyja E; Oziębło A; Mandat T; Bujko M
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686289
[TBL] [Abstract][Full Text] [Related]
16. Small Non-Coding RNAs in Soft-Tissue Sarcomas: State of the Art and Future Directions.
La Ferlita A; Sp N; Goryunova M; Nigita G; Pollock RE; Croce CM; Beane JD
Mol Cancer Res; 2023 Jun; 21(6):511-524. PubMed ID: 37052491
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in the Pathogenesis, Prognostication and Prediction of Treatment Resistance in Soft Tissue Sarcomas.
Teo AYT; Lim VY; Yang VS
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765536
[TBL] [Abstract][Full Text] [Related]
18. miR-193b-3p Promotes Proliferation of Goat Skeletal Muscle Satellite Cells through Activating IGF2BP1.
Li L; Zhang X; Yang H; Xu X; Chen Y; Dai D; Zhan S; Guo J; Zhong T; Wang L; Cao J; Zhang H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555418
[TBL] [Abstract][Full Text] [Related]
19. New Insights on the Nuclear Functions and Targeting of FAK in Cancer.
Pomella S; Cassandri M; Braghini MR; Marampon F; Alisi A; Rota R
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216114
[TBL] [Abstract][Full Text] [Related]
20. FAK in Cancer: From Mechanisms to Therapeutic Strategies.
Chuang HH; Zhen YY; Tsai YC; Chuang CH; Hsiao M; Huang MS; Yang CJ
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
